Literature DB >> 14552503

Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands.

Ignacio Mata1, Catherine M Gilvarry, Peter B Jones, Shôn W Lewis, Robin M Murray, Pak C Sham.   

Abstract

There remains disagreement over whether increased risk of schizotypal personality disorder (SPD) is confined to the relatives of patients with a diagnosis of schizophrenia or whether it is a more general characteristic of the relatives of all psychotic patients. To examine the relationship between schizotypal dimensions in relatives and psychopathological syndromes in patients with functional psychoses, factor analysis was carried out on (1) ratings from Present State Examination (PSE) interviews with 172 consecutively admitted patients with psychosis (52% of them with schizophrenia), and (2) ratings on items from three schizotypal scales concerning 263 of their nonpsychotic first degree relatives. The factors derived from the patients' PSE interviews were correlated with the schizotypal factors and the nine DSM-IV criteria for SPD concerning the relatives and subjected to a canonical correlation analysis. In this study, no differences were observed concerning the distribution of schizotypal factors or DSM-IV schizotypal features in the relatives of patients with different psychotic diagnoses. However, a syndrome characterized by delusions, hallucinations, and thought interference (positive symptoms) in patients was correlated with high scores on the three schizotypy scales and with positive and negative schizotypal features in relatives.

Entities:  

Mesh:

Year:  2003        PMID: 14552503     DOI: 10.1093/oxfordjournals.schbul.a007004

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  Heritability and longitudinal stability of schizotypal traits during adolescence.

Authors:  Marissa Ericson; Catherine Tuvblad; Adrian Raine; Kelly Young-Wolff; Laura A Baker
Journal:  Behav Genet       Date:  2011-03-03       Impact factor: 2.805

2.  Subjective experience of cognitive failures as possible risk factor for negative symptoms of psychosis in the general population.

Authors:  Stefanie Pfeifer; Jim van Os; Manon Hanssen; Philippe Delespaul; Lydia Krabbendam
Journal:  Schizophr Bull       Date:  2008-02-21       Impact factor: 9.306

3.  Adaptive evolution of genes underlying schizophrenia.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Proc Biol Sci       Date:  2007-11-22       Impact factor: 5.349

Review 4.  Dimensions and the psychosis phenotype.

Authors:  Judith Allardyce; Trisha Suppes; Jim Van Os
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

5.  A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals.

Authors:  Saskia de Leede-Smith; Emma Barkus
Journal:  Front Hum Neurosci       Date:  2013-07-16       Impact factor: 3.169

Review 6.  Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia.

Authors:  Ulrich Ettinger; Inga Meyhöfer; Maria Steffens; Michael Wagner; Nikolaos Koutsouleris
Journal:  Front Psychiatry       Date:  2014-02-21       Impact factor: 4.157

Review 7.  Genetic Consideration of Schizotypal Traits: A Review.

Authors:  Emma E Walter; Francesca Fernandez; Mollie Snelling; Emma Barkus
Journal:  Front Psychol       Date:  2016-11-15

Review 8.  Developmental Aspects of Schizotypy and Suspiciousness: a Review.

Authors:  Keri K Wong; Adrian Raine
Journal:  Curr Behav Neurosci Rep       Date:  2018-02-09

9.  Lifetime prevalence and potential determinants of psychotic experiences in the general population of Qatar.

Authors:  Salma M Khaled; Stacy Schantz Wilkins; Peter Woodruff
Journal:  Psychol Med       Date:  2019-05-28       Impact factor: 7.723

10.  The meaning of momentary psychotic-like experiences in a non-clinical sample: A personality perspective.

Authors:  Goran Knežević; Ljiljana B Lazarević; Aleksandar Zorić
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.